TURNOVER (x1000 DKK)
NET PROFIT (x1000 DKK)
EMPLOYEES
Pharma Nord ApS
Closing information (x1000 DKK)
| Closing information | 2024/12 | 2023/12 | 2022/12 |
| Turnover |
486,691
|
447,388
|
439,437 |
| Earnings before taxes |
39,304
|
26,023
|
43,076 |
| Total assets |
405,332
|
427,094
|
447,011 |
| Current assets |
184,374
|
226,142
|
260,517 |
| Current liabilities |
198,067
|
200,416
|
195,687 |
| Equity capital |
143,344
|
160,565
|
183,029 |
| - share capital |
200
|
200
|
200 |
| Employees (average) |
150
|
150
|
150 |
Financial ratios
| Fiscal year | 2024/12 | 2023/12 | 2022/12 |
| Solvency |
35.4%
|
37.6%
|
40.9% |
| Turnover per employee |
3,245
|
2,983
|
2,930 |
| Profit as a percentage of turnover |
8.1%
|
5.8%
|
9.8% |
| Return on assets (ROA) | |||
| Current ratio |
93.1%
|
112.8%
|
133.1% |
| Return on equity (ROE) |
27.4%
|
16.2%
|
23.5% |
| Change turnover |
39,303
|
7,951
|
-30,743 |
| Change turnover % |
9%
|
2%
|
-7% |
| Chg. No. of employees |
0
|
0
|
0 |
| Chg. No. of employees % |
0%
|
0%
|
0% |
Total value of public sale
| Fiscal year | 2024/12 | 2023/12 | 2022/12 |
| Total value of public sale |
0
|
0
|
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.